Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Neural effects of psychedelics: Complexity the key word
    Published on 2024-04-16
    2 years ago
  • In vivo translocator protein in females with autism spectrum disorder: a pilot study
    Published on 2024-04-13
    2 years ago
  • Rebound activation of 5-HT neurons following SSRI discontinuation
    Published on 2024-04-12
    2 years ago
  • Beyond traditional pharmacology: evaluating phosphodiesterase inhibitors in autism spectrum disorder
    Published on 2024-04-11
    2 years ago
  • AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects
    Published on 2024-04-10
    2 years ago
  • The selective D3Receptor antagonist VK4-116 reverses loss of insight caused by self-administration of cocaine in rats
    Published on 2024-04-06
    2 years ago
  • Author Correction: Sex differences in offspring risk and resilience following 11β-hydroxylase antagonism in a rodent model of maternal immune activation
    Published on 2024-04-05
    2 years ago
« Previous 1 … 99 100 101 102 103 … 143 Next »
Journal of Psychopharmacology
  • Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review
    Published on 2021-05-28
    5 years ago
  • ‘Memory, hither come’: Psychopharmacology of memory and more
    Published on 2021-05-27
    5 years ago
  • Altered cerebellar-cortical resting-state functional connectivity in cannabis users
    Published on 2021-05-26
    5 years ago
  • Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice
    Published on 2021-05-19
    5 years ago
  • The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects
    Published on 2021-05-05
    5 years ago
  • Role of the norepinephrine transporter polymorphisms in atomoxetine treatment: From response to side effects in children with ADHD
    Published on 2021-05-04
    5 years ago
  • Challenges in translational research: MDMA in the laboratory versus therapeutic settings
    Published on 2021-05-04
    5 years ago
« Previous 1 … 99 100 101 102 103 … 154 Next »
European Neuropsychopharmacology
  • Monitoring inflammation in psychiatry: Caveats and advice
    Published on 2021-10-02
    5 years ago
  • Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis
    Published on 2021-09-29
    5 years ago
  • Glutamate modulators and beyond: A neuroscience revolution in the making
    Published on 2021-09-25
    5 years ago
  • Cannabis use and psychosis susceptibility: A call to action
    Published on 2021-09-24
    5 years ago
  • The cognitive anxiety sensitivity treatment (CAST) in anxiety prevention – Focus on separation anxiety and interoception
    Published on 2021-09-16
    5 years ago
  • Biomarkers of response to rapid-acting antidepressants
    Published on 2021-09-15
    5 years ago
  • Opioid use and misuse in Europe: COVID-19 new challenges?
    Published on 2021-09-14
    5 years ago
« Previous 1 … 99 100 101 102 103 … 170 Next »

   Pharma Pub